Megan Lipscey
Investment Director, Invest Venture·RA Capital Management
Bio
Professional summary
Megan Lipscey is an Investment Director on RA Capital's Venture Team, where her primary responsibility is conducting due diligence on biotechnology companies. Before joining RA Capital, she worked as a Gastroenterology Fellow at the University of Pittsburgh Medical Center and as an internal medicine resident at Beth Israel Deaconess Medical Center. Her background combines clinical training with business education in entrepreneurship and strategic management.
Background
Career, education, and skills
Career history
- RA Capital ManagementInvestment Director, VenturePresent
- University of Pittsburgh Medical CenterGastroenterology Fellow
- Beth Israel Deaconess Medical CenterResident Physician, Internal Medicine
Education
- University of FloridaBS in Microbiology & Cell Science
- Tulane School of MedicineMD
- A.B. Freeman School of Business, Tulane UniversityMBA in Entrepreneurship & Strategic Management
Other partners at RA Capital Management
12 more profiles
Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Allison Harrigan
Senior Director Corporate Development
RA Capital Management
Raven corporate development leader focused on biotech company creation.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.